Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07648771

Outcomes Registry After Ketamine Infusions for Chronic Pain: A Longitudinal Evaluation

Sponsor: Stanford University

View on ClinicalTrials.gov

Summary

Ketamine is an anesthetic drug that is sometimes used to relieve chronic pain. The goal of this observational study is to learn about how patients respond to ketamine infusions for chronic pain. Note: This study does not provide ketamine - instead, this study uses surveys to follow patients who are already scheduled to receive ketamine infusions as part of their regular medical care. We will also follow a second group of patients who were recommended ketamine infusions by their doctor but were denied insurance coverage for this treatment. These participants will complete the same surveys for up to 16 weeks, starting from when their treatment was originally scheduled. Comparing this group to patients who received ketamine will help researchers better understand ketamine's effects and how insurance denials affect chronic pain patients.

Official title: Nationwide Observational Registry of Patient Outcomes Following Ketamine Infusion Therapy for Chronic Pain

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

800

Start Date

2026-10

Completion Date

2034-12

Last Updated

2026-09-15

Healthy Volunteers

No

Interventions

DRUG

Ketamine (Ketalar)

Intravenous ketamine infusion delivered as part of routine clinical care

Locations (1)

Stanford Health Care

Stanford, California, United States